CJC-1295 (No DAC) 5mg + Ipamorelin 5mg – Research Peptide Blend
Our CJC-1295 (No DAC) 5mg + Ipamorelin 5mg is a high-purity, research-grade peptide blend developed for laboratory studies focused on growth hormone signaling, peptide interactions, and endocrine pathway analysis. This dual-peptide formulation is widely used in research settings examining how GHRH analogs and ghrelin receptor agonists function together at the molecular level.
CJC-1295 (No DAC) is commonly studied as a growth hormone-releasing hormone (GHRH) analog, while Ipamorelin is a selective ghrelin receptor agonist. In research environments, this combination is often explored for its synergistic role in growth hormone pulse modulation and receptor-specific signaling.
Key Features
- 5mg CJC-1295 (No DAC) + 5mg Ipamorelin (10mg total)
- High-purity, research-grade peptide formulation
- Designed for laboratory research and analytical use only
- Commonly studied for growth hormone pathway signaling and peptide synergy
- Lyophilized powder for stability and precise handling
Research Applications
- Growth hormone (GH) signaling and release studies
- GHRH and ghrelin receptor interaction research
- Endocrine and metabolic pathway analysis
- Peptide interaction and signaling cascade studies
Quality & Handling
Manufactured and prepared for use in controlled laboratory environments, this lyophilized peptide blend supports accurate reconstitution and consistent research application.
IMPORTANT DISCLAIMER:
FOR RESEARCH PURPOSES ONLY. NOT APPROVED FOR HUMAN OR VETERINARY CONSUMPTION.
There are no reviews yet.